Smart ring manufacturer Ultrahuman has resumed sales in the United States following a resolution to a patent dispute with competitor Oura. The company’s new Ring Pro is now available for preorder after being cleared by US Customs and Border Protection, marking its return to a key market.
The Patent Battle and Ultrahuman’s Response
The conflict began in August 2025 when the US International Trade Commission ruled against Ultrahuman and Ringconn in a patent case brought by Oura, concerning the internal design of their rings. Ringconn settled with Oura, but Ultrahuman halted sales of its Ring Air while developing the Ring Pro to avoid further legal issues.
This move was crucial because smart ring technology is a rapidly evolving space, and intellectual property disputes can significantly impact market access.
Ring Pro: Key Features and Pricing
Ultrahuman’s Ring Pro boasts impressive specifications: up to 15 days of battery life on a single charge, extendable to over 45 days with the optional charging case. Unlike Oura, it provides core health data – including sleep, recovery, movement, stress, and circadian rhythms – without a subscription fee, though advanced metrics require a separate subscription.
Other notable features include:
- A redesigned heart-rate sensor
- Dual-core processor for on-chip machine learning
- 250 days of on-device health data storage
- Emergency-release design (the ring can be safely cut apart if needed)
Preorders start at $349 for the ring and case, increasing to $399 afterward. The charging case is available separately for $100 or as a bundle for $479. The ring comes in black, silver, gold, and titanium finishes.
Beyond the Ring: Ultrahuman’s Expansion
Ultrahuman has expanded beyond smart rings to become a broader health tech company. Recent developments include:
- A home device for sleep environment monitoring
- Ovulation tracking functionality
- AFib detection
- FDA-approved migraine insights
- Real-time glucose monitoring via separate sensors
- Blood biomarker analysis through its Blood Vision service
This diversification signals Ultrahuman’s ambition to compete with Oura not just in the ring market but across multiple health tracking categories. The company’s CEO, Mohit Kumar, emphasized their engineering-focused approach, believing that innovation will ultimately determine success in this space.
Ultrahuman’s re-entry into the US market demonstrates its resilience and commitment to the wearable health tech sector. By resolving the patent dispute and launching a competitive product, the company is poised to challenge Oura’s dominance and provide consumers with more options in the growing smart ring category.
